News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Françoise Meunier Highlighted Study on Five-Year Survival in Young Breast Cancer Patients
Françoise Meunier
Jun 12, 2025, 18:16

Françoise Meunier Highlighted Study on Five-Year Survival in Young Breast Cancer Patients

Françoise Meunier, Founder of the European Initiative on Ending Discrimination Against Cancer Survivors, shared a post on LinkedIn:

“A highly relevant new publication in the Journal of the National Cancer Center highlights why Member States must act decisively when transposing the Consumer Credit Directive into national law and when adopting the national legal framework with a 5-year timeline:
‘Five-year conditional relative survival up to 10 years post-diagnosis among adolescent and young adult breast cancer patients’
The data shows that for most adolescent and young adult breast cancer survivors; excess mortality becomes minimal within just a few years. This is exactly the kind of evidence that justifies a 5-year timeframe for the Right to Be Forgotten.
This is a pivotal moment for policymakers: transposing the Directive with ambition and evidence in mind is critical to protecting cancer survivors from ongoing financial discrimination.”

Title: Five-year conditional relative survival up to 10 years post-diagnosis among adolescent and young adult breast cancer patients by age, stage, and receptor subtype

Journal: The National Cancer Center

Authors: Noëlle J.M.C. Vrancken Peeters, Daniël J. van der Meer, Marleen Kok, Marissa C. van Maaren, Marie-Jeanne T.F.D. Vrancken Peeters, Sabine Siesling, Winette T.A. van der Graaf, Olga Husson

Read the full article.

Breast Cancer

More posts featuring Françoise Meunier on OncoDaily.

cancer cancer survivors Consumer Credit Directive Daniël J. van der Meer Françoise Meunier Journal of the National Cancer Center Marie-Jeanne T.F.D. Vrancken Peeters Marissa C. van Maaren Marleen Kok Noëlle J.M.C. Vrancken Peeters Olga Husson OncoDaily Oncology Sabine Siesling Winette T.A. van der Graaf
Special Coverage
Insight
Jul 3, 2025, 17:51
Maximilian Merz: How to Train Your Virtual Twin with 10 Million Euros
Blog
Jul 3, 2025, 17:40
Susanna Fletcher Greer: Striving to Support the Whole Person Behind the Science at the V Foundation
Opinion
Jul 3, 2025, 17:35
Andrew M Wardley: The Essential Role of a Cancer Plan in Shaping the Future of Cancer Care in the UK
Career
Jul 3, 2025, 17:22
George Yaghmour: Honored to Be Named The Leukemia and Lymphoma Society’s 2025 All-Star Top Fundraiser with 255,826 Dollars
Blog
Jul 3, 2025, 17:10
Oliver Bogler: Why I am Learning a New Way to Support Scientists
Blog
Jul 3, 2025, 17:01
Annalisa Saetta: Palliative Care Clerkship Increased Students’ Knowledge and Appreciation for a Holistic Approach
Blog
Jul 3, 2025, 16:46
Priscilla Chan: Accelerating Imaging Science so Researchers Can See Biology More Clearly
Insight
Jul 3, 2025, 16:42
Highlights From ESMO Gastrointestinal Cancers Congress 2025 by Arndt Vogel
Career
Jul 3, 2025, 16:19
David Weinstock Has Been Appointed Head of the Oncology Disease Translational Area in pRED at Roche
Career
Jul 3, 2025, 16:10
Bruno Vialli Has Been Appointed LATAM Procurement Manager for Media, Comms and Events at Sanofi
Insight
Jul 3, 2025, 16:01
Paolo Tarantino: First Positive Phase 3 Trial for a Bispecific ADC
Insight
Jul 3, 2025, 15:48
ASMIRT shares updates on advocacy, research, and student support in Australia - ESTRO